Sayama, Japan

Hiroshi Okazaki


Average Co-Inventor Count = 11.6

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1980-1982

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Hiroshi Okazaki: Innovator in Antibacterial and Anti-Tumor Research

Introduction

Hiroshi Okazaki is a prominent inventor based in Sayama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial and anti-tumor agents. With a total of 8 patents to his name, Okazaki's work has had a substantial impact on medical science.

Latest Patents

Among his latest patents, Okazaki has developed .alpha.-Substituted ureido-benzylpenicillanic acids. These compounds, along with their pharmaceutically acceptable salts, exhibit high antibacterial activities against both Gram-positive and Gram-negative bacteria, especially those of the genus Pseudomonas. Additionally, he has created an anti-tumor preparation that contains cells of Streptococcus equisimilis, which undergo heat treatment in a salt solution, with or without penicillin treatment, to enhance its efficacy against certain tumors.

Career Highlights

Hiroshi Okazaki is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His innovative research and development efforts have positioned him as a key figure in the advancement of therapeutic agents that combat serious bacterial infections and tumors.

Collaborations

Okazaki has collaborated with notable colleagues, including Haruki Ogawa and Takao Noto. Their combined expertise has contributed to the successful development of various pharmaceutical innovations.

Conclusion

Hiroshi Okazaki's contributions to the fields of antibacterial and anti-tumor research highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence medical treatments and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…